60 Degrees Pharmaceuticals Inc (SXTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 127 | 63 | 22 | 0 | 318 |
| Cost of Goods | 71 | 184 | 73 | N/A | 92 |
| Gross Profit | 56 | -121 | -52 | N/A | 226 |
| Operating Expenses | 1,649 | 851 | 972 | 0 | 534 |
| Operating Income | -1,522 | -788 | -951 | N/A | -215 |
| Interest Expense | 40 | 1,100 | 1,141 | 0 | 1,216 |
| Other Income | 5,736 | -1,456 | -505 | 0 | -19 |
| Pre-tax Income | 4,174 | -3,344 | -2,598 | 0 | -1,450 |
| Net Income Continuous | 4,174 | -3,344 | -2,598 | N/A | -1,451 |
| Minority Interests | -10 | -7 | 3 | N/A | -3 |
| Net Income | $4,183 | $-3,337 | $-2,600 | $N/A | $-1,448 |
| EPS Basic Total Ops | 182.60 | -336.80 | -271.31 | N/A | -146.46 |
| EPS Basic Continuous Ops | 186.32 | -337.74 | -270.68 | N/A | -145.98 |
| EPS Diluted Total Ops | 182.60 | -336.80 | -271.31 | N/A | -146.46 |
| EPS Diluted Continuous Ops | 186.32 | -337.74 | -270.68 | N/A | -145.98 |
| EBITDA(a) | $-1,313 | $-215 | $-228 | $N/A | $287 |